Donegan Michael C's Form 4 filing
TherapeuticsMD, Inc. (TXMD) · filed Jan 25, 2023
- Accession no.
- 0001209191-23-004871
- Filed
- Jan 25, 2023
- Trade date
- Jan 23-24, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $6.99K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Donegan Michael CCIK 0001627810 | Officer (Prin. Fin. and Acctg. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2023 | Common Stock | MOption exerciseAcquired | +380 | $0.00 | $0 | 4,934 | Direct | |
| Jan 23, 2023 | Common Stock | MOption exerciseAcquired | +1,066 | $0.00 | $0 | 6,000 | Direct | |
| Jan 23, 2023 | Common Stock | MOption exerciseAcquired | +519 | $0.00 | $0 | 6,519 | Direct | |
| Jan 23, 2023 | Common Stock | MOption exerciseAcquired | +2,400 | $0.00 | $0 | 8,919 | Direct | |
| Jan 23, 2023 | Common Stock | SSaleDisposed | −1,302 | $5.34 | −$6,952.68 | 7,617 | Direct | |
| Jan 24, 2023 | Common Stock | SSaleDisposed | −7 | $5.31 | −$37.17 | 7,610 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2023 | Common Stock | MOption exerciseDisposed | −380 | $0.00 | $0 | 0 | Direct | |
| Jan 23, 2023 | Common Stock | MOption exerciseDisposed | −1,066 | $0.00 | $0 | 0 | Direct | |
| Jan 23, 2023 | Common Stock | MOption exerciseDisposed | −519 | $0.00 | $0 | 0 | Direct | |
| Jan 23, 2023 | Common Stock | MOption exerciseDisposed | −2,400 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.